835 related articles for article (PubMed ID: 25349290)
1. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
Gondi V; Pugh SL; Tome WA; Caine C; Corn B; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Shah S; Shi W; Wendland M; Kachnic L; Mehta MP
J Clin Oncol; 2014 Dec; 32(34):3810-6. PubMed ID: 25349290
[TBL] [Abstract][Full Text] [Related]
2. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
Martinage G; Hong AM; Fay M; Thachil T; Roos D; Williams N; Lo S; Fogarty G
Radiat Oncol; 2018 Jul; 13(1):132. PubMed ID: 30029684
[TBL] [Abstract][Full Text] [Related]
3. [Memory protection with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases?].
Kortmann RD
Strahlenther Onkol; 2015 Jun; 191(6):534-5. PubMed ID: 26221646
[No Abstract] [Full Text] [Related]
4. CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933.
Caine C; Deshmukh S; Gondi V; Mehta M; Tomé W; Corn BW; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Raben A; Shi W; Wendland M; Kachnic L
J Neurooncol; 2016 Jan; 126(2):327-36. PubMed ID: 26511494
[TBL] [Abstract][Full Text] [Related]
5. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL
J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal-avoidance whole-brain radiation therapy: a new standard for patients with brain metastases?
Suh JH
J Clin Oncol; 2014 Dec; 32(34):3789-91. PubMed ID: 25349293
[No Abstract] [Full Text] [Related]
7. Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial.
Yang WC; Chen YF; Yang CC; Wu PF; Chan HM; Chen JL; Chen GY; Cheng JC; Kuo SH; Hsu FM
Neuro Oncol; 2021 Mar; 23(3):478-486. PubMed ID: 32789503
[TBL] [Abstract][Full Text] [Related]
8. Does Hippocampal-Avoidance Whole-Brain Radiotherapy for Brain Metastases Meaningfully Change Current Practice?
Chamberlain MC
J Clin Oncol; 2015 Jun; 33(17):1985. PubMed ID: 25897152
[No Abstract] [Full Text] [Related]
9. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
[TBL] [Abstract][Full Text] [Related]
10. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).
Grosu AL; Frings L; Bentsalo I; Oehlke O; Brenner F; Bilger A; Fennell JT; Rothe T; Schneider-Fuchs S; Graf E; Schmoor C; Beck J; Becker G; Bock M; Egger K; Urbach H; Lahmann C; Popp I
BMC Cancer; 2020 Jun; 20(1):532. PubMed ID: 32513138
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.
Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY
Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128
[TBL] [Abstract][Full Text] [Related]
12. Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol.
Chia BSH; Leong JY; Ong ALK; Lim C; Poon SH; Chua MLK; Chua KLM; Kusumawidjaja G; Chua ET; Wong FY; Lee TS
BMC Cancer; 2020 Oct; 20(1):1045. PubMed ID: 33126867
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer.
Westover KD; Mendel JT; Dan T; Kumar K; Gao A; Pulipparacharuv S; Iyengar P; Nedzi L; Hannan R; Anderson J; Choe KS; Jiang W; Abdulrahman R; Rahimi A; Folkert M; Laine A; Presley C; Cullum CM; Choy H; Ahn C; Timmerman R
Neuro Oncol; 2020 Dec; 22(12):1831-1839. PubMed ID: 32347302
[TBL] [Abstract][Full Text] [Related]
14. Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases.
Lebow ES; Hwang WL; Zieminski S; Wang Y; Niemierko A; Mehan WA; Oh KS; Khandekar M; Willers H; Shih HA
J Neurooncol; 2020 May; 148(1):81-88. PubMed ID: 32307637
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
Brown PD; Gondi V; Pugh S; Tome WA; Wefel JS; Armstrong TS; Bovi JA; Robinson C; Konski A; Khuntia D; Grosshans D; Benzinger TLS; Bruner D; Gilbert MR; Roberge D; Kundapur V; Devisetty K; Shah S; Usuki K; Anderson BM; Stea B; Yoon H; Li J; Laack NN; Kruser TJ; Chmura SJ; Shi W; Deshmukh S; Mehta MP; Kachnic LA;
J Clin Oncol; 2020 Apr; 38(10):1019-1029. PubMed ID: 32058845
[TBL] [Abstract][Full Text] [Related]
16. A prospective evaluation of hippocampal radiation dose volume effects and memory deficits following cranial irradiation.
Ma TM; Grimm J; McIntyre R; Anderson-Keightly H; Kleinberg LR; Hales RK; Moore J; Vannorsdall T; Redmond KJ
Radiother Oncol; 2017 Nov; 125(2):234-240. PubMed ID: 29128167
[TBL] [Abstract][Full Text] [Related]
17. Reply to M.C. Chamberlain.
Kotecha R; Suh JH
J Clin Oncol; 2015 Jun; 33(17):1986-7. PubMed ID: 25897164
[No Abstract] [Full Text] [Related]
18. Reply to M.C. Chamberlain.
Gondi V; Tome WA; Mehta MP
J Clin Oncol; 2015 Jun; 33(17):1986. PubMed ID: 25897163
[No Abstract] [Full Text] [Related]
19. Evaluating the impact of hippocampal sparing during whole brain radiotherapy on neurocognitive functions: A preliminary report of a prospective phase II study.
Lin SY; Yang CC; Wu YM; Tseng CK; Wei KC; Chu YC; Hsieh HY; Wu TH; Pai PC; Hsu PW; Chuang CC
Biomed J; 2015; 38(5):439-49. PubMed ID: 25994802
[TBL] [Abstract][Full Text] [Related]
20. Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases - the first Australian experience.
Awad R; Fogarty G; Hong A; Kelly P; Ng D; Santos D; Haydu L
Radiat Oncol; 2013 Mar; 8():62. PubMed ID: 23497418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
